Jinhe Biotechnology CO., LTD.

SZSE:002688.SZ

4.69 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008
Operating Activities:
Net Income 94.434118.04122.089139.193190.328164.404110.047174.233115.75780.07990.63289.5676.92853.21426.04115.87
Depreciation & Amortization 179.293155.895132.078119.95499.44686.3372.41756.24454.141.92637.10138.55138.41234.42731.8230
Deferred Income Tax 6.6922.7472.401-9.82-9.5372.129-29.539103.129-0.5270000000
Stock Based Compensation 7.52000000000000000
Change In Working Capital -166.209-217.889-182.684-89.925-101.86-205.719-211.86927.32222.007-186.12914.149-56.855-29.05712.009-48.0070
Accounts Receivables -183.895-152.491-138.635-8.2198.606-58.482-135.121-29.056-27.349-114.737-38.654-48.2960000
Inventory 11.515-105.566-135.583-19.85-62.977-28.91-35.4157.223-11.428-175.546-10.285-10.9954.886-5.851-6.7470
Accounts Payables -0.52137.42189.133-52.036-37.951-120.457-11.793-53.97461.3110000000
Other Working Capital 3.8442.7472.401-9.82-9.537-176.81-176.45420.09933.435-10.58324.435-45.86-33.94217.86-41.2590
Other Non Cash Items 56.4268.42581.49688.85794.27172.1656.65834.61223.1036.1086.44117.5520.30818.39813.338-15.87
Operating Cash Flow 198.766124.471152.979258.08282.186117.17527.253292.412214.966-58.016148.32388.806106.591118.04923.19511.637
Investing Activities:
Investments In Property Plant And Equipment -457.217-402.157-383.722-204.008-178.849-170.179-196.568-128.566-142.083-348.523-160.551-34.501-39.428-54.796-23.002-27.5
Acquisitions Net -60.87817.45-19.2430.001-6.901-20.419-3.132-86.364-4.26348.523160.6710054.88600
Purchases Of Investments -9-4.2-0.1-0.10-1.423-28.46-225.615-276-130-30-17.036-0.069-1.16900
Sales Maturities Of Investments 3.75405.38-0.0010026.4340.27651.265131.14630.296001.00200
Other Investing Activites -10.8542.111-0.3-0.31.665-20.419-83.188-55.9020.05-348.523-160.551-34.501-0-54.796-23.002-27.5
Investing Cash Flow -534.188-386.796-397.986-204.408-184.085-192.021-284.917-456.171-371.027-347.376-160.136-51.537-39.497-54.873-23.002-27.5
Financing Activities:
Debt Repayment -600.257-995.527-1,573.933-1,102.777-900.935-677.699-432.816-827.992-302.252-170-220-355.5-307.289-383.9-334.4-219.123
Common Stock Issued 0131.892000-1.450000000000
Common Stock Repurchased 0-131.89200000000000000
Dividends Paid -75.375-40.549-63.529-158.822-158.821-65.143-141.7-98.768-40.419-31.904-56.472-14.564-16.274-15.572-22.378-15.961
Other Financing Activities -38.5131,186.5092,126.9691,353.261937.779896.408828.51,133.865538.798480.795190.063618.43283.015320.232362.231318.049
Financing Cash Flow 413.051150.433448.70327.604-185.941153.566253.984207.105196.127278.891-86.409248.366-40.548-79.2395.45382.965
Other Information:
Effect Of Forex Changes On Cash 9.07421.611-2.157-7.1471.5341.4030.0251.6251.5640.059-0.016-0.022-0.055-0.0220.003-0.002
Net Change In Cash 86.702-90.281201.53974.128-86.30680.123-3.65544.9741.631-126.442-98.238285.61326.491-16.0855.64867.1
Cash At End Of Period 497.63410.927501.208299.669225.541311.847231.724235.379190.409148.778275.22373.45887.84461.35477.43971.791